One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver

Int J Mol Sci. 2021 May 29;22(11):5851. doi: 10.3390/ijms22115851.

Abstract

The prevalence of nonalcoholic fatty liver disease (NAFLD) has been rapidly increasing worldwide. A choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) has been used to create a mouse model of nonalcoholic steatohepatitis (NASH). There are some reports on the effects on mice of being fed a CDAHFD for long periods of 1 to 3 months. However, the effect of this diet over a short period is unknown. Therefore, we examined the effect of 1-week CDAHFD feeding on the mouse liver. Feeding a CDAHFD diet for only 1-week induced lipid droplet deposition in the liver with increasing activity of liver-derived enzymes in the plasma. On the other hand, it did not induce fibrosis or cirrhosis. Additionally, it was demonstrated that CDAHFD significantly impaired mitochondrial respiration with severe oxidative stress to the liver, which is associated with a decreasing mitochondrial DNA copy number and complex proteins. In the gene expression analysis of the liver, inflammatory and oxidative stress markers were significantly increased by CDAHFD. These results demonstrated that 1 week of feeding CDAHFD to mice induces steatohepatitis with mitochondrial dysfunction and severe oxidative stress, without fibrosis, which can partially mimic the early stage of NASH in humans.

Keywords: CDAHFD; NASH; liver; mitochondrial dysfunction; oxidative stress.

MeSH terms

  • Animals
  • Biomarkers
  • Choline Deficiency / complications*
  • Diet, High-Fat / adverse effects*
  • Disease Models, Animal
  • Disease Susceptibility
  • Gluconeogenesis
  • Inflammation Mediators / metabolism
  • Lipid Droplets / metabolism
  • Lipid Metabolism
  • Lipogenesis
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology
  • Mice
  • Mitochondria / drug effects*
  • Mitochondria / metabolism*
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Oxidative Stress*
  • Phenotype

Substances

  • Biomarkers
  • Inflammation Mediators